After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Posts navigation Older postsNewer posts